Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. (Q53496509)

14 May 2018

title

Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. (English)

1 reference

14 May 2018

1 reference

Mei-Jen Chuang

1

1 reference

14 May 2018

Kuang-Hui Sun

2

1 reference

14 May 2018

Shye-Jye Tang

3

1 reference

14 May 2018

Ming-Wei Deng

4

1 reference

14 May 2018

Yu-Hsin Wu

5

1 reference

14 May 2018

Jung-Sung Sung

6

1 reference

14 May 2018

Tai-Lung Cha

7

1 reference

14 May 2018

Guang-Huan Sun

8

1 reference

14 May 2018

publication date

18 February 2008

1 reference

14 May 2018

published in

Cancer Science

1 reference

14 May 2018

volume

99

1 reference

14 May 2018

page(s)

905-913

1 reference

14 May 2018

issue

5

1 reference

14 May 2018

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

The von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

21 January 2018

Focus on kidney cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00756.X

10.1111/J.1349-7006.2008.00756.X

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

18294286

1 reference

14 May 2018